Efficacy of two artemisinin combination therapies for uncomplicated falciparum malaria in children under 5 years, Malakal, Upper Nile, Sudan.
BACKGROUND
The treatment for Plasmodium falciparum malaria in Sudan has been in process of change since 2003. Preceding the change, this study aimed to determine which artemisinin-based combination therapies is more effective to treat uncomplicated malaria in Malakal, Upper Nile, Sudan.


METHODS
Clinical trial to assess the efficacy of 2 antimalarial therapies to treat P. falciparum infections in children aged 6-59 months, in a period of 42 days after treatment.


RESULTS
A total of 269 children were followed up to 42 days. Artesunate plus Sulfadoxine/Pyrimethamine (AS+SP) and Artesunate plus Amodiaquine (AS+AQ) were both found to be efficacious in curing malaria infections by rapid elimination of parasites and clearance of fever, in preventing recrudescence and suppressing gametocytaemia. The combination of AS+SP appeared slightly more efficacious than AS+AQ, with 4.4% (4/116) versus 15% (17/113) of patients returning with malaria during the 6-week period after treatment (RR = 0.9, 95% CI 0.81-0.96). PCR analysis identified only one recrudescence which, together with one other early treatment failure, gave efficacy rates of 99.0% for AS+AQ (96/97) and 99.1% for AS+SP (112/113). However, PCR results were incomplete and assuming part of the indeterminate samples were recrudescent infections leads to an estimated efficacy ranging 97-98% for AS+SP and 88-95% for AS+AQ.


CONCLUSIONS
These results lead to the recommendation of ACT, and specifically AS+SP, for the treatment of uncomplicated falciparum malaria in this area of Sudan. When implemented, ACT efficacy should be monitored in sentinel sites representing different areas of the country.
van den Broek
Ingrid
I
Manson's Unit, MSF -UK, 67-74 Saffron Hill, London EC1N, UK. ingrid.van.den.broek@london.msf.org
Amsalu
Ribka
R
Balasegaram
Manica
M
Hepple
Pamela
P
Alemu
Engudaye
E
Hussein
El Badri
el B
Al-Faith
Muhammed
M
Montgomery
Jacqui
J
Checchi
Francesco
F
D000655:Amodiaquine / Q000008:administration & dosage* / Q000494:pharmacology; D000962:Antimalarials / Q000008:administration & dosage / Q000494:pharmacology / Q000592:standards*; D037621:Artemisinins / Q000008:administration & dosage* / Q000494:pharmacology; D000077332:Artesunate; D002675:Child, Preschool; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007223:Infant; D016778:Malaria, Falciparum / Q000188:drug therapy*; D008297:Male; D011739:Pyrimethamine / Q000008:administration & dosage* / Q000494:pharmacology; D012717:Sesquiterpenes / Q000008:administration & dosage* / Q000494:pharmacology; D013397:Sudan; D013413:Sulfadoxine / Q000008:administration & dosage* / Q000494:pharmacology
D000962:Antimalarials; D037621:Artemisinins; D004338:Drug Combinations; D012717:Sesquiterpenes; D000655:Amodiaquine; C001205:fanasil, pyrimethamine drug combination; D000077332:Artesunate; D013413:Sulfadoxine; D011739:Pyrimethamine
Lancet. 2000 Jan 29;355(9201):352-7
10665554
Trans R Soc Trop Med Hyg. 2003 Mar-Apr;97(2):229-35
14584383
Am J Trop Med Hyg. 2003 Feb;68(2):133-9
12641400
Lancet. 2002 Apr 20;359(9315):1365-72
11978332
Trans R Soc Trop Med Hyg. 1999 Jul-Aug;93(4):369-74
10674079
Trop Med Int Health. 2003 Dec;8(12):1068-73
14641841
Antimicrob Agents Chemother. 2004 Apr;48(4):1329-34
15047537
Trop Med Int Health. 2004 Sep;9(9):975-80
15361110
Trans R Soc Trop Med Hyg. 2005 Jul;99(7):548-54
15869770
Clin Pharmacokinet. 1996 Apr;30(4):263-99
8983859
Trop Doct. 1996 Apr;26(2):89-90
8685983
Ann Trop Med Parasitol. 2004 Oct;98(7):661-6
15509420